Redeye updates on G5 after Q2-results which showed weaker sales than expected, while results were cl...
Redeye considers AAC's Q2 to be solid with net sales of SEK112m (+52% y/y) landing 1% above our SEK1...
RaySearch’s Q2 figures were largely known following the July profit warning.
Q2 adjusted EBITDA was EUR 3.1m, clearly above our estimate of EUR 2.
Redeye comments on Freja eID's Q2 report, showing lower q/q ARR growth but solid profitability, with...
Redeye comments on Embracer’s Q1-results which were stronger-than-expected driven by solid growth in...
Both of Redeye's tests for the case held this quarter: customers kept building, and BeammWave kept i...
The main highlight of the second quarter was the clear improvement in order bookings including four ...
While Q2 was below our expectations, the company has given a clear message that it aims to protect m...
* Beat across all three segments * 34% sales and 65% EBIT beat * '26e/'27e group EBIT raised 16%/8% ...
Redeye leaves a brief comment following ExpreS2ion’s announcement of the third scheduled DSMB review...
Redeye provides its initial take following the release of Argo's Q2 2026 report.
EQL Pharma inleder 2026/27 med en oförändrad omsättning på 107 MSEK och en försvagad lönsamhet.
BeammWave surprised by stating it is advancing a global tier-1 Asian technology partner from an init...
LAIQON turned EBITDA positive in Q2 for the first time in years and Digital Wealth is scaling fast e...
* Sales SEK 1,558m & EBIT 68m * Earnings beat across all segments * Share currently trading at 15-10...
Taaleri’s Q2 2026 continuing earnings of EUR 9.8m declined by 8% y/y and came 7% below our estimate.
JonDeTech redovisade fortsatt begränsade intäkter men minskad rörelseförlust och stärkt finansiering...
Redeye provides an update following Neem's Hill's Q2 2026 report.
Redeye updates on Better Collective ahead of Q2-results (due 20 August after market close) where we ...
